Hospital Dr Peset

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Dermatomyositis and polymyositis (myositis)1 trial
• Multiple myeloma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• PETHEMA Foundation1 trial
• Spanish Lung Cancer Group1 trial

Running trials

• Not yet recruiting

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

  NCT03589222· Phase 2· PETHEMA Foundation· Source

• Recruiting

  Thoracic Tumours Register

  NCT02941458· Spanish Lung Cancer Group· Source

  Contact: María Martín, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting